Search

Helpdesk

Sales contact

Home > Resources > Televisits for more engaging clinical trials

Televisits for more engaging clinical trials

23 November 2022

If it is important to enable televisits for DCT trials, embedding the feature directly into the eCOA app brings multiple benefits for patients and sites.

Follow us on social media

Subscribe to our newsletter

You may also like

Kayentis enlists experts in oncology, neurodegenerative and metabolic disorders to...

The unquestionable value of electronic Clinical Outcome Assessments (eCOA) in...

Breaking barriers in pediatric clinical trials: perspectives from two expert...

Ensure successful outcomes with strong patient collaboration at every stage...

Empowering healing: The impact of patient partnerships in clinical trials

Collecting PRO data in leukemia clinical research: the only way...

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Meet us at the following events

C-PATH 2025

APR 9-10 2025 • Rockville, Maryland, USA

OCT Europe 2025

APR 29-30 2025 • Barcelona, Spain

Booth #74 15th Annual Outsourcing in Clinical Trials Europe 2025 - Arena International

OCT East Coast 2025

MAY 20-21 2025 • King of Prussia, USA

Booth #44 16th Annual Outsourcing in Clinical Trials East Coast 2025 - Arena International

PCMG 2025

JUNE 10-12 2025 • Malaga, Spain

PCMG Annual Assembly 2025

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA